{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:32:54Z","timestamp":1789471974922,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002957","name":"Technische Universit\u00e4t Dresden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003390","name":"Fritz Thyssen Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003390","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.clim.2019.108327","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T05:43:08Z","timestamp":1576647788000},"page":"108327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["High-dose intravenous methylprednisolone in juvenile non-infectious uveitis: A retrospective analysis"],"prefix":"10.1016","volume":"211","author":[{"given":"Anja","family":"Schnabel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Normi","family":"Br\u00fcck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Berner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Range","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Holl-Wieden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henner","family":"Morbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Leszczynska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Bau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M.","family":"Hedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clim.2019.108327_bb0005","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1034\/j.1600-0420.2000.078001084.x","article-title":"Uveitis in children: population-based study in Finland","volume":"78","author":"Paivonsalo-Hietanen","year":"2000","journal-title":"Acta Ophthalmol. Scand."},{"issue":"2","key":"10.1016\/j.clim.2019.108327_bb0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.iio.0000155903.87679.c2","article-title":"Uveitis in children","volume":"45","author":"Zierhut","year":"2005","journal-title":"Int. Ophthalmol. Clin."},{"issue":"1","key":"10.1016\/j.clim.2019.108327_bb0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12969-016-0088-2","article-title":"Juvenile idiopathic arthritis-associated uveitis","volume":"14","author":"Clarke","year":"2016","journal-title":"Pediatr. Rheumatol. Online J."},{"issue":"6","key":"10.1016\/j.clim.2019.108327_bb0020","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaapos.2008.03.007","article-title":"Course, complications, and outcome of juvenile arthritis-related uveitis","volume":"12","author":"Sabri","year":"2008","journal-title":"J. AAPOS"},{"issue":"5","key":"10.1016\/j.clim.2019.108327_bb0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/ICU.0000000000000501","article-title":"What is new in paediatric uveitis?","volume":"29","author":"LaMattina","year":"2018","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"1","key":"10.1016\/j.clim.2019.108327_bb0030","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2012.07.052","article-title":"Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the systemic immunosuppressive therapy for eye diseases study","volume":"120","author":"Gregory","year":"2013","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.clim.2019.108327_bb0035","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.ophtha.2004.06.014","article-title":"Ocular complications of pediatric uveitis","volume":"111","author":"Rosenberg","year":"2004","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.clim.2019.108327_bb0040","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ajo.2006.11.025","article-title":"Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis","volume":"143","author":"Woreta","year":"2007","journal-title":"Am J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.clim.2019.108327_bb0045","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ajo.2008.11.009","article-title":"Chronic anterior uveitis in children: clinical characteristics and complications","volume":"147","author":"Holland","year":"2009","journal-title":"Am J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.clim.2019.108327_bb0050","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.ophtha.2009.12.003","article-title":"Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids","volume":"117","author":"Thorne","year":"2010","journal-title":"Ophthalmology"},{"issue":"17","key":"10.1016\/j.clim.2019.108327_bb0055","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa1614160","article-title":"Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis","volume":"376","author":"Ramanan","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.clim.2019.108327_bb0060","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/annrheumdis-2018-213131","article-title":"Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative","volume":"77","author":"Constantin","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.clim.2019.108327_bb0065","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/acr.23871","article-title":"2019 American College of Rheumatology\/Arthritis Foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis","volume":"71","author":"Angeles-Han","year":"2019","journal-title":"Arthritis Care Res."},{"issue":"5","key":"10.1016\/j.clim.2019.108327_bb0070","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00296-011-2126-1","article-title":"Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis","volume":"32","author":"Heiligenhaus","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.clim.2019.108327_bb0075","series-title":"Heiligenhaus AMKTCBHBBDCFIFDFMGGG. S2k-Leitlinie045-012: Diagnostikundantientz\u00fcndlicheTherapiederUveitisbeijuveniler idiopathischerArthriti","year":"2018"},{"issue":"7","key":"10.1016\/j.clim.2019.108327_bb0080","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/acr.21625","article-title":"Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis","volume":"64","author":"DeWitt","year":"2012","journal-title":"Arthritis Care Res."},{"issue":"1","key":"10.1016\/j.clim.2019.108327_bb0085","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.clim.2019.108327_bb0090","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/acr.21558","article-title":"Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus","volume":"64","author":"Mina","year":"2012","journal-title":"Arthritis Care Res."},{"issue":"1","key":"10.1016\/j.clim.2019.108327_bb0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12969-016-0069-5","article-title":"Medication use in juvenile uveitis patients enrolled in the childhood arthritis and rheumatology research Alliance registry","volume":"14","author":"Henderson","year":"2016","journal-title":"Pediatr. Rheumatol. Online J."},{"issue":"2","key":"10.1016\/j.clim.2019.108327_bb0100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/09273948.2011.646382","article-title":"High-dose intravenous corticosteroids for ocular inflammatory diseases","volume":"20","author":"Charkoudian","year":"2012","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"3","key":"10.1016\/j.clim.2019.108327_bb0105","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.clim.2019.108327_bb0110","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0161-6420(01)00576-0","article-title":"Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients","volume":"108","author":"Samson","year":"2001","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.clim.2019.108327_bb0115","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ajo.2008.03.004","article-title":"Mycophenolate mofetil for the treatment of uveitis","volume":"146","author":"Teoh","year":"2008","journal-title":"Am J. Ophthalmol."},{"issue":"8","key":"10.1016\/j.clim.2019.108327_bb0120","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.ophtha.2005.02.020","article-title":"Mycophenolate mofetil therapy for inflammatory eye disease","volume":"112","author":"Thorne","year":"2005","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.clim.2019.108327_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2009.04.020","article-title":"Methotrexate for ocular inflammatory diseases","volume":"116","author":"Gangaputra","year":"2009","journal-title":"Ophthalmology"},{"issue":"10050","key":"10.1016\/j.clim.2019.108327_bb0130","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","article-title":"Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial","volume":"388","author":"Nguyen","year":"2016","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.clim.2019.108327_bb0135","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/rheumatology\/ken298","article-title":"Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis","volume":"47","author":"Simonini","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.clim.2019.108327_bb0140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00296-009-1213-z","article-title":"One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behcet\u2019s disease refractory to standard immunosuppressive drugs","volume":"31","author":"Giardina","year":"2011","journal-title":"Rheumatol. Int."},{"issue":"10","key":"10.1016\/j.clim.2019.108327_bb0145","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in patients with active noninfectious uveitis","volume":"375","author":"Jaffe","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"5703","key":"10.1016\/j.clim.2019.108327_bb0150","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/278456a0","article-title":"Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation","volume":"278","author":"Flower","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.clim.2019.108327_bb0155","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.2147\/OPTH.S68595","article-title":"Targeting interleukin-6 for noninfectious uveitis","volume":"9","author":"Lin","year":"2015","journal-title":"Clin. Ophthalmol."},{"issue":"5","key":"10.1016\/j.clim.2019.108327_bb0160","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000055677","article-title":"Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis","volume":"33","author":"Santos Lacomba","year":"2001","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.clim.2019.108327_bb0165","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.exer.2015.06.018","article-title":"Expression profile of IL-1 family cytokines in aqueous humor and sera of patients with HLA-B27 associated anterior uveitis and idiopathic anterior uveitis","volume":"138","author":"Zhao","year":"2015","journal-title":"Exp. Eye Res."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166161930525X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166161930525X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:00:23Z","timestamp":1761494423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166161930525X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":33,"alternative-id":["S152166161930525X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2019.108327","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-dose intravenous methylprednisolone in juvenile non-infectious uveitis: A retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2019.108327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108327"}}